As of August 28, 2026, ACADIA Pharmaceuticals Inc. (ACAD) has a DilutionWatch DilutionScore of 12/100, rated LOW dilution risk. ACADIA Pharmaceuticals Inc. has a market capitalization of $3.71B, 172.31M shares outstanding, 346 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ACAD.
Market Data
Market Cap$3.71B
Shares Outstanding172.31M
Float127.34M
Cash$384.99M
Debt$22.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 8.2% shares (2026Q1 vs prior)
346 institutional holders · 182.42M shares
#1
BAKER BROS. ADVISORS LP
42.90M shares
#2
BlackRock, Inc.
21.55M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
11.32M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest10.81M
Days to Cover8.0
% of Float8.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track ACAD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ACAD — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ACAD
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.